Fibrocor, a MaRS Innovation portfolio company, announces deal with Galapagos
January 07, 2019 10:43 ET | MaRS Innovation
Toronto, ON, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Fibrocor Therapeutics, a privately held Canadian company, and Galapagos NV, a Belgo-Dutch pharmaceutical research company, have announced the formation...
Banning Long-lining in Galapagos Islands
November 04, 2014 02:38 ET | Ocearch
PARK CITY, Utah, Nov. 4, 2014 (GLOBE NEWSWIRE) -- Science and Management work together to ban long-lining in Galapagos – issue highlighted by killing of shark in marine reserve Modern...
Galapagos Announces Changes to Board of Directors
May 24, 2005 02:06 ET | Galapagos Genomics
MECHELEN, Belgium, May 24, 2005 (PRIMEZONE) -- Galapagos NV, a genomics-based drug discovery company, announces changes to its Board of Directors. In view of Galapagos' listing on Euronext Amsterdam...